Epidural	epidural	O	O	O	O
blood	blood	O	O	O	O
flow	flow	O	O	O	O
during	during	O	O	O	O
prostaglandin	prostaglandin	CHEMICALS	O	OTHERS	I
E1	e1	CHEMICALS	O	OTHERS	I
or	or	O	O	O	O
trimethaphan	trimethaphan	O	O	OTHERS	I
induced	induced	O	O	O	O
hypotension	hypotension	O	DISEASE	OTHERS	I
.	.	O	O	O	O

To	to	O	O	O	O
evaluate	evaluate	O	O	O	O
the	the	O	O	O	O
effect	effect	O	O	O	O
of	of	O	O	O	O
prostaglandin	prostaglandin	CHEMICALS	O	OTHERS	I
E1	e1	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
PGE1	pge1	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
or	or	O	O	O	O
trimethaphan	trimethaphan	O	O	OTHERS	I
(	(	O	O	O	O
TMP	tmp	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
induced	induced	O	O	O	O
hypotension	hypotension	O	DISEASE	OTHERS	I
on	on	O	O	O	O
epidural	epidural	O	O	O	O
blood	blood	O	O	O	O
flow	flow	O	O	O	O
(	(	O	O	O	O
EBF	ebf	O	O	O	O
)	)	O	O	O	O
during	during	O	O	O	O
spinal	spinal	O	O	O	O
surgery	surgery	O	O	O	O
,	,	O	O	O	O
EBF	ebf	O	O	O	O
was	was	O	O	O	O
measured	measured	O	O	O	O
using	using	O	O	O	O
the	the	O	O	O	O
heat	heat	O	O	O	O
clearance	clearance	O	O	O	O
method	method	O	O	O	O
in	in	O	O	O	O
30	30	O	O	O	O
patients	patients	O	O	O	O
who	who	O	O	O	O
underwent	underwent	O	O	O	O
postero-lateral	postero-lateral	O	O	O	O
interbody	interbody	O	O	O	O
fusion	fusion	O	O	O	O
under	under	O	O	O	O
isoflurane	isoflurane	CHEMICALS	O	OTHERS	I
anaesthesia	anaesthesia	O	O	O	O
.	.	O	O	O	O

An	an	O	O	O	O
initial	initial	O	O	O	O
dose	dose	O	O	O	O
of	of	O	O	O	O
0.1	0.1	O	O	O	O
microgram.kg-1.min-1	microgram.kg-1.min-1	O	O	O	O
of	of	O	O	O	O
PGE1	pge1	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
15	15	O	O	O	O
patients	patients	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
or	or	O	O	O	O
10	10	O	O	O	O
micrograms.kg-1.min-1	micrograms.kg-1.min-1	O	O	O	O
of	of	O	O	O	O
TMP	tmp	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
15	15	O	O	O	O
patients	patients	O	O	O	O
)	)	O	O	O	O
was	was	O	O	O	O
administered	administered	O	O	O	O
intravenously	intravenously	O	O	O	O
after	after	O	O	O	O
the	the	O	O	O	O
dural	dural	O	O	O	O
opening	opening	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
dose	dose	O	O	O	O
was	was	O	O	O	O
adjusted	adjusted	O	O	O	O
to	to	O	O	O	O
maintain	maintain	O	O	O	O
the	the	O	O	O	O
mean	mean	O	O	O	O
arterial	arterial	O	O	O	O
blood	blood	O	O	O	O
pressure	pressure	O	O	O	O
(	(	O	O	O	O
MAP	map	O	O	OTHERS	I
)	)	O	O	O	O
at	at	O	O	O	O
about	about	O	O	O	O
60	60	O	O	O	O
mmHg	mmhg	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
hypotensive	hypotensive	O	DISEASE	OTHERS	I
drug	drug	O	O	O	O
was	was	O	O	O	O
discontinued	discontinued	O	O	O	O
at	at	O	O	O	O
the	the	O	O	O	O
completion	completion	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
operative	operative	O	O	O	O
procedure	procedure	O	O	O	O
.	.	O	O	O	O

After	after	O	O	O	O
starting	starting	O	O	O	O
PGE1	pge1	CHEMICALS	O	OTHERS	I
or	or	O	O	O	O
TMP	tmp	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
MAP	map	O	O	OTHERS	I
and	and	O	O	O	O
rate	rate	O	O	O	O
pressure	pressure	O	O	O	O
product	product	O	O	O	O
(	(	O	O	O	O
RPP	rpp	O	O	O	O
)	)	O	O	O	O
decreased	decreased	O	O	O	O
significantly	significantly	O	O	O	O
compared	compared	O	O	O	O
with	with	O	O	O	O
preinfusion	preinfusion	O	O	O	O
values	values	O	O	O	O
(	(	O	O	O	O
P	p	O	O	OTHERS	I
<	<	O	O	O	O
0.01	0.01	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
degree	degree	O	O	O	O
of	of	O	O	O	O
hypotension	hypotension	O	DISEASE	OTHERS	I
due	due	O	O	O	O
to	to	O	O	O	O
PGE1	pge1	CHEMICALS	O	OTHERS	I
remained	remained	O	O	O	O
constant	constant	O	O	O	O
until	until	O	O	O	O
60	60	O	O	O	O
min	min	O	O	O	O
after	after	O	O	O	O
its	its	O	O	O	O
discontinuation	discontinuation	O	O	O	O
.	.	O	O	O	O

Heart	heart	O	O	O	O
rate	rate	O	O	O	O
(	(	O	O	O	O
HR	hr	O	O	O	O
)	)	O	O	O	O
did	did	O	O	O	O
not	not	O	O	O	O
change	change	O	O	O	O
in	in	O	O	O	O
either	either	O	O	O	O
group	group	O	O	O	O
.	.	O	O	O	O

EBFF	ebff	O	O	O	O
did	did	O	O	O	O
not	not	O	O	O	O
change	change	O	O	O	O
during	during	O	O	O	O
PGE1	pge1	CHEMICALS	O	OTHERS	I
infusion	infusion	O	O	O	O
whereas	whereas	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
TMP	tmp	CHEMICALS	O	OTHERS	I
group	group	O	O	O	O
,	,	O	O	O	O
EBF	ebf	O	O	O	O
decreased	decreased	O	O	O	O
significantly	significantly	O	O	O	O
at	at	O	O	O	O
30	30	O	O	O	O
and	and	O	O	O	O
60	60	O	O	O	O
min	min	O	O	O	O
after	after	O	O	O	O
the	the	O	O	O	O
start	start	O	O	O	O
of	of	O	O	O	O
TMP	tmp	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
preinfusion	preinfusion	O	O	O	O
:	:	O	O	O	O
45.9	45.9	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
13.9	13.9	O	O	O	O
ml/100g/min	ml/100g/min	O	O	O	O
.	.	O	O	O	O

30	30	O	O	O	O
min	min	O	O	O	O
:	:	O	O	O	O
32.3	32.3	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
9.9	9.9	O	O	O	O
ml/100	ml/100	O	O	O	O
g/min	g/min	O	O	O	O
(	(	O	O	O	O
P	p	O	O	OTHERS	I
<	<	O	O	O	O
0.05	0.05	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

60	60	O	O	O	O
min	min	O	O	O	O
:	:	O	O	O	O
30	30	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
7.5	7.5	O	O	O	O
ml/100	ml/100	O	O	O	O
g/min	g/min	O	O	O	O
(	(	O	O	O	O
P	p	O	O	OTHERS	I
<	<	O	O	O	O
0.05	0.05	O	O	O	O
)	)	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

These	these	O	O	O	O
results	results	O	O	O	O
suggest	suggest	O	O	O	O
that	that	O	O	O	O
PGE1	pge1	CHEMICALS	O	OTHERS	I
may	may	O	O	O	O
be	be	O	O	O	O
preferable	preferable	O	O	O	O
to	to	O	O	O	O
TMP	tmp	CHEMICALS	O	OTHERS	I
for	for	O	O	O	O
hypotensive	hypotensive	O	DISEASE	OTHERS	I
anaesthesia	anaesthesia	O	O	O	O
in	in	O	O	O	O
spinal	spinal	O	O	O	O
surgery	surgery	O	O	O	O
because	because	O	O	O	O
TMP	tmp	CHEMICALS	O	OTHERS	I
decreased	decreased	O	O	O	O
EBF	ebf	O	O	O	O
.	.	O	O	O	O

